This is a preview of subscription content, log in via an institution to check access.
Reference
NICE. NICE draft guidance recommends nivolumab for advanced skin cancer. Media Release : 22 Jan 2016. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
NICE recommends nivolumamb for advanced melanoma. PharmacoEcon Outcomes News 745, 37 (2016). https://doi.org/10.1007/s40274-016-2778-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2778-x